Skip to content
Sunday, November 22, 2026Independent education · Evidence in contextOur standards
MedicalGenetics.Science for life. Knowledge for care.
HomeGenetics toolsSource watchEveryday geneticsClinical practiceFor researchersArticle libraryTrusted resources
Home2026

Year: 2026

A focused perturbation target illustrates gene-function screening; it is not a clinical editing procedure.
Functional genomics

CRISPR screens: from a selected hit to a defensible mechanism

October 22, 2026 Medical Genetics editorial team Comments Off on CRISPR screens: from a selected hit to a defensible mechanism
A screen identifies candidates under particular experimental conditions; orthogonal evidence is needed before treating a hit as a disease mechanism or therapeutic target.

[…]

A schematic activity gauge reads 40%, separated by a not-equal sign from a question about disease probability. The value is invented for teaching; assay activity cannot be read directly as a patient’s disease probability.
Functional genomics

Functional variant assays: abnormal biology is not automatically pathogenicity

October 22, 2026 Medical Genetics editorial team Comments Off on Functional variant assays: abnormal biology is not automatically pathogenicity
Read functional variant evidence critically: calibration, PS3/BS3, BRCA1 experiments and what a normal or abnormal assay can miss.

[…]

Methylation markers on a DNA segment illustrate an epigenetic pattern, not a diagnostic episignature.
Epigenetics

DNA methylation episignatures: biomarkers with a defined scope

October 22, 2026 Medical Genetics editorial team Comments Off on DNA methylation episignatures: biomarkers with a defined scope
A reproducible methylation pattern can support a diagnosis, but classifier coverage and validation determine how much it can resolve.

[…]

Four sample circles, each containing four cell symbols, show that cells are grouped within four independent donors. The cell symbols are illustrative and do not depict the 1,000 cells per donor in the article’s worked example.
Functional genomics

Single-cell genomics: more cells do not replace more participants

October 22, 2026 Medical Genetics editorial team Comments Off on Single-cell genomics: more cells do not replace more participants
Learn why donor numbers matter in single-cell studies, with a worked example, pseudobulk comparison and checks for confounding.

[…]

A continuous long read bridges a repeated region between two unique flanks.
Genomic technologies

Long-read sequencing after a negative genetic test: what can it add?

October 22, 2026 Medical Genetics editorial team Comments Off on Long-read sequencing after a negative genetic test: what can it add?
Understand when long-read sequencing may help after an inconclusive test, with examples of phase, repeat expansions and diagnostic-yield claims.

[…]

A transcript connects two retained exons across an omitted middle exon. The example is generic, not a specific gene.
Molecular diagnostics

Clinical RNA sequencing: what it can reveal after a genetic test

October 22, 2026 Medical Genetics editorial team Comments Off on Clinical RNA sequencing: what it can reveal after a genetic test
Learn what RNA sequencing can reveal about splicing and expression, with practical examples, tissue limitations and evidence from long-read RNA studies.

[…]

Three sample comparisons represent mother, father and child. No variant is assigned a clinical classification.
Genomic testing

Trio sequencing: what parents’ samples can reveal about a genetic result

October 22, 2026 Medical Genetics editorial team Comments Off on Trio sequencing: what parents’ samples can reveal about a genetic result
Explore trio sequencing with examples of de novo variants, recessive inheritance and unaffected parents, plus questions about consent and follow-up.

[…]

Two distinct sample contexts show that tumour findings and inherited-risk testing answer different questions.
Cancer Genetics

Tumour vs germline testing: how to resolve discordant reports

October 22, 2026 Medical Genetics editorial team Comments Off on Tumour vs germline testing: how to resolve discordant reports
Why tumour and germline reports can differ, when genetics input helps, and what information makes a useful referral. Includes practical examples.

[…]

Two overlapping illustrative curves represent uncertain risk distributions, not a validated polygenic score or patient estimate.
Complex disease genetics

Polygenic risk scores: how to read a result and judge the evidence

October 22, 2026 Medical Genetics editorial team Comments Off on Polygenic risk scores: how to read a result and judge the evidence
Understand polygenic risk scores with practical examples of percentiles, calibration and clinical usefulness, plus a checklist for reviewing research.

[…]

Three carriers are shown schematically: one without a marked feature and two with different feature intensity. No population risk is implied.
Inheritance

Penetrance vs expressivity: the difference, with examples

October 22, 2026 Medical Genetics editorial team Comments Off on Penetrance vs expressivity: the difference, with examples
Learn how penetrance differs from expressivity, why age matters, and why inheriting a variant is not the same as developing a condition.

[…]

Posts pagination

« 1 … 11 12 13 »

Recent Posts

  • Personalised base editing: what an individual-patient result can show
  • Newborn genome screening: benefits, limits and follow-up
  • 22q11.2 deletion syndrome: one genetic diagnosis, different health needs
  • X-linked hypophosphatemia: connect phosphate loss with PHEX testing
  • TTR T60A (Thr80Ala): what the variant name means

Recent Comments

No comments to show.
Medical Genetics

Clear explanations. Traceable evidence. A thoughtful view of genetics across everyday life, clinical care and research.

Publisher & medical editor: Saeed Reza Ghaffari, MD, MSc, PhD
Medical Genetics Specialist · About the publisher

Learning resourcesTrusted resourcesSource watchAboutEditorial policyPrivacyContact
© 2026 Medical Genetics. Educational information, not individual medical advice. Article review status and sources are shown separately. No affiliation with similarly named journals or professional societies is implied.